Studies have shown that neoadjuvant nivolumab may provide long-term benefits for people with non-small cell lung cancer.

Published Date: 17 Feb 2023

BACKGROUND: NSCLC is the most common and important cause of cancer worldwide. Assessment: The patient...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

New imaging solution could help improve survival for patients with recurring prostate cancer

2.

In MDS at Lower Risk, Novel Therapy Diminished Transfusion Dependency.

3.

What Could This Exploratory 5-Year Survival Data in Adjuvant NSCLC Treatment Mean?

4.

Screening for prostate cancer: is it time to give up digital rectal examination?

5.

Scientists hail the cervical cancer treatment as the most remarkable breakthrough in 20 years.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot